Optometrists in Wheeling, WV Accepting Medicare
8 Optometrists found. Showing 1 - 8
 Dr. Douglas Kent Graebe, O. D. Optometrist Medicare: Medicare Enrolled Practice Location: 50 Washington Ave, Wheeling, WV 26003 Phone: 740-695-3822 Fax: 740-695-3822 |
Dr. John Scott Pockl, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2106 Lumber Ave, Wheeling, WV 26003 Phone: 304-242-5544 Fax: 304-242-2560 |
Dr. Peter G Dormas, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2106 Lumber Ave, Wheeling, WV 26003 Phone: 304-242-5544 |
 Kathryn M Clark, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2101 Jacob St. Suite 201, Valley Prof. Center South, Wheeling, WV 26003 Phone: 304-242-9245 Fax: 304-242-6870 |
Joseph M. Bannon, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1021 National Rd, Wheeling, WV 26003 Phone: 304-234-4455 Fax: 304-234-4452 |
 Eyecare Center Of Wheeling Optometrist Medicare: Medicare Enrolled Practice Location: 2106 Lumber Ave, Wheeling, WV 26003 Phone: 304-242-5544 Fax: 304-242-2560 |
Joseph M. Bannon Od Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 1021 National Rd, Wheeling, WV 26003 Phone: 304-234-4455 |
Dr. Donald Raymond Taylor, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2106 Lumber Ave, Wheeling, WV 26003 Phone: 304-242-5544 Fax: 304-242-2560 |
News Archive
Hospira second-quarter 2010 net sales increase 1.2% to $968 million
Hospira, Inc., a leading global specialty pharmaceutical and medication delivery company, today reported results for the second quarter ended June 30, 2010. Net sales for the quarter were $968 million, and adjusted diluted earnings per share were $0.86.
BioTrends Research Group releases Wave 2 report on AMAG's Feraheme
BioTrends Research Group, Inc. released Wave 2 of its LaunchTrends(TM): Feraheme report, the second in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15.
AF AWARE campaign launches Atrial Fibrillation in Primary Care tool
The AF AWARE campaign today, at the European Society of Cardiology (ESC) Congress 2011 in Paris, announces the launch of the Atrial Fibrillation in Primary Care (AFIP) tool, developed to help primary care physicians (PCPs) with early diagnosis and optimal management of patients with atrial fibrillation.
Discovery could provide new approaches to treat metabolic disorders
Scientists from the Florida campus of The Scripps Research Institute have identified a novel synthetic activator of a pair of proteins that belong to a protein family playing key roles in human metabolism and immune function. The discovery could provide new and potentially more effective therapeutic approaches to diseases ranging from diabetes to osteoporosis.
Phase 1 study data of Keryx' perifosine for recurrent pediatric solid tumors presented at ASCO
Keryx Biopharmaceuticals, Inc. today announced that Phase 1 data of KRX-0401 (perifosine) in recurrent pediatric solid tumors was presented yesterday in the pediatric solid tumor poster discussion session held at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago, IL.
› Verified 7 days ago
Physical Therapists
Speech-Language Pathologists
Occupational Therapists
Podiatrists
Optometrists
Chiropractors
Audiologists